The primary pharmaceutical regulatory authority has instructed companies producing two frequently prescribed cough and cold medications and a painkiller drug, all available in fixed dose combinations (FDCs) for over three decades, to conduct trials for the reassessment of their safety and effectiveness. FDC entails the amalgamation of two or more drugs in a set ratio to create a unified dosage form.
Posted from: this blog via Microsoft Power Automate.